Recorded Webinar from Nov 9, 2017

 

Assessing the immunogenicity of biopharmaceuticals

 

Immunogenicity of therapeutic biopharmaceuticals can impact both the efficacy and the safety of the product. Assessment of anti-drug antibodies (ADAs) as well as neutralizing antibodies (NAbs) is a fundamental part of immunogenicity testing. 

 

By listening to this webinar, you will learn:

  • how the Gyrolab™ platform automates drug-tolerant ADA immunoassays in a time-efficient way using small volumes of patient samples and reagents
  • how iLite® Assay Ready reporter gene cell lines are designed to overcome limitations of conventional cell-based assays in the assessment of neutralizing antibodies

Speakers:

 

Cecilia Bill-webb.pngCecilia Bill,
Application Scientist, Gyros Protein Technologies AB

 

 

 

 

 

Frida Pauly.pngFrida Pauly,
Manager Biopharma Solutions, Euro Diagnostica AB

 

 

 

 

 

If you have problems to view the webinar please contact maritha.lundin@gyrosproteintech.com

Fill in form to access the webinar